Tag: <span>Pulmonary</span>

Home / Pulmonary
Post

Why Are We Undertreating So Many Pulmonary Embolisms?

LONG BEACH, California — A small fraction of patients with pulmonary embolism (PE) who are eligible for advanced therapies are actually getting them, reported investigators who conducted a big data analysis. “Advanced PE therapy seems to be vulnerable to disparate use, and perhaps underuse,” Sahil Parikh, MD, a cardiovascular interventionalist at the Columbia University Medical...

Lung Cancer and Nail Clubbing
Post

Lung Cancer and Nail Clubbing

By Dr. Sanchari Sinha Dutta, Ph.D. Reviewed by Emily Henderson, B.Sc. Nail clubbing is characterized by specific changes around and under the toe and fingernails that are caused by certain diseases. Lung cancer is the most frequent cause of nail clubbing. What is nail clubbing? Nail clubbing, also called digital clubbing or Hippocratic nail, is...

The CNIO pave the way for a future gene therapy to reverse pulmonary fibrosis associated with ageing
Post

The CNIO pave the way for a future gene therapy to reverse pulmonary fibrosis associated with ageing

CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) DEVELOPMENT OF THE INITIAL STAGES OF PULMONARY FIBROSIS ASSOCIATED WITH AGEING IN NON-TREATED MICE (LEFT), THAT CAN BE PREVENTED IN MICE TREATED WITH THE TELOMERASE GENE THERAPY (RIGHT). view more CREDIT: CNIO Idiopathic pulmonary fibrosis is a potentially lethal disease for which there is currently no cure and that...

Novateur Ventures explores new strategy to reduce hyperinflammatory response caused by COVID-19
Post

Novateur Ventures explores new strategy to reduce hyperinflammatory response caused by COVID-19

VASCULAR LEAKAGE, INFLAMMATION-PROVOKING, AND THROMBOTIC EVENTS IN CORONAVIRUS DISEASE 2019 view more CREDIT: NOVATEUR VENTURES A novel strategy has been developed by Novateur Ventures, which provides new hope in battle against COVID-19. The study titled ‘A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes’ was published in Frontiers in Pharmacology, a...

Chinese Study Finds COVID-19 Patients Still Suffer From Lung Damage Three Months After Being Discharged
Post

Chinese Study Finds COVID-19 Patients Still Suffer From Lung Damage Three Months After Being Discharged

A new study found the majority of Chinese patients recovering from COVID-19 still suffer from lung damage three months after being discharged from the hospital. Zhongnan Hospital of Wuhan University Intensive Care Director Dr. Peng Zhiyong published his findings on his research on the impact of COVID-19 on patients’ health after recovery. This was the...

Lung Link
Post

Lung Link

Harvard Medical School researchers at Boston Children’s Hospital and Brigham and Women’s Hospital will soon begin testing an existing drug, dornase alfa, in patients with severe COVID-19 pneumonia and respiratory failure. The randomized, controlled clinical trial aims to enroll 60 adults and children over age 3 who require mechanical ventilation. Dornase alfa, also known as...

Post

New system uses X-ray images of patients’ lungs to diagnose COVID-19

Reviewed by James Ives, M.Psych. (Editor) Researchers from the Department of Computer Architecture and Technology at the University of Seville’s School of Computer Engineering (ETSII) are working on a system that uses X-ray images of patients’ lungs to help diagnose COVID-19. This system uses deep learning to train a neural network model that can distinguish...

Post

International recommendations for nontuberculous mycobacteria

GERMAN CENTER FOR INFECTION RESEARCH NTMs are closely related to tuberculosis bacteria and can (but do not need to) cause infectious diseases in humans. They are called “nontuberculous mycobacteria” (NTMs) to distinguish them from tuberculosis bacteria. There are approximately 200 different species and subspecies of these bacteria. Patients with bronchiectasis (dilation of the airways) are...

Yale, Baylor create detailed atlas of cellular change in lungs with fibrosis
Post

Yale, Baylor create detailed atlas of cellular change in lungs with fibrosis

A research team from Yale and Baylor College of Medicine has completed the largest single-cell analysis to date of lungs affected by Idiopathic Pulmonary Fibrosis (IPF), revealing how cells change in response to the disease and identifying previously unknown cell types. The findings, published in the issue of Science Advances, deepen understanding of IPF and...

Medscape Medical News ‘Doc, Can I Get a Mask Exemption?’
Post

Medscape Medical News ‘Doc, Can I Get a Mask Exemption?’

Laura A. Stokowski, RN, MSDISCLOSURES July 07, 2020 Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. As more jurisdictions mandate facial coverings in public, questions have arisen about whether it’s safe for everyone — including those with lung disease — to wear masks. Stories about people who claim to...